|Bid||7.39 x 1400|
|Ask||7.40 x 1400|
|Day's Range||7.11 - 7.42|
|52 Week Range||4.61 - 10.82|
|Beta (5Y Monthly)||1.18|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 02, 2023 - May 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.00|
Subscribe to Yahoo Finance Plus to view Fair Value for VYGR
Key Insights Voyager Therapeutics' significant individual investors ownership suggests that the key decisions are...
Q4 2022 Voyager Therapeutics Inc Earnings Call
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -7.02% and 112.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?